Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO CEO & Investor ...( SEATTLE Feb. 6 /- Cell Therapeuti...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO CEO & Investor Conference
Date:2/6/2008
SEATTLE, Feb. 6 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTAX) management will present at the 10th Annual BIO CEO & Investor Conference on Tuesday, February 12th at 1:15 PM in the West Foyer of the Waldorf-Astoria Hotel.
The presentation will also be webcast live with slides, and available
for replay after the presentation. The webcast can be accessed at
http://www.cticseattle.com.
BIO CEO & Investor Conference
CTI Presentation: Tuesday, February 12, 2008
1:15 PM EST/7:15 PM CET/10:15 AM PST
West Foyer, Waldorf-Astoria Hotel
Audio webcast with slides at http://www.cticseattle.com
Media Contact: Investors Contact:
Cell Therapeutics, Inc. Cell Therapeutics, Inc.
Dan Eramian Leah Grant
T: 206.272.4343 T: 206.272.4345
F: 206.272.4434 F: 206.272.4434
Susan Callahan E: invest@ctiseattle.com
T: 206.272.4472
F: 206.272.4434
http://www.cticseattle.com/media.htm
'/>"/>
| SOURCE Cell Therapeutics, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Nile Therapeutics, Inc. to Present at Upcoming BIO CEO & Investor Conference
2. Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease
3. Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimers Treatments
4. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
5. Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders
6. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
7. Cell Therapeutics, Inc. (CTI) Prices $1.27 million (euros 856.000) Offering of Common Stock through Societe Generale
8. Cell Therapeutics, Inc. Announces Authorization to Publish Italian Listing Prospectus
9. Cell Therapeutics, Inc. (CTI) Hosts Conference Call to Discuss Update on Zevalin(R) Acquisition, CMS Reimbursement, and PIX301 Timeline
10. Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
11. Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule
Post Your Comments:
(Date:12/5/2008)... JERSEY CITY, New Jersey, December 5,/PRNewswire-...SG ), an,innovative molecular diagnostic company ...y its consolidated financial results for the quart...ts. , The company recorded revenues for the...s were recorded from the date of acquisition of Pa...
(Date:12/5/2008)... /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYS... company that identifies, develops and commerciali..., today reported that Oncoscience AG, the European...YM BioSciences Inc., has withdrawn its application...ting authorization of nimotuzumab. Withdrawal of a...
(Date:12/5/2008)...PRNewswire-Asia-FirstCall/ -- China Sky One Medica...) (Nasdaq: CSKI ), a leading,fully integrated p...rugs in,the People,s Republic of China ("PRC"), a...EO and President of China Sky One Medical took par...The China Perspective. , As a well-known ph...
(Date:12/4/2008)...wire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI",...nounced that a single,institutional investor shal...Convertible Senior Notes due 2011 (the "Notes"), w... The new Notes would have a $32.65 million init...ovision entitling the holder, upon any conversion ...
Breaking Biology Technology:Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 2Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 3Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 4Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 5Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 6Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 7Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 8Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 9Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 10YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE 2YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE 3China Sky One Medical, Inc. Interviewed in The China Perspective 2China Sky One Medical, Inc. Interviewed in The China Perspective 3Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes 3[0] Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS[0] YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE[0] China Sky One Medical, Inc. Interviewed in The China Perspective[0] Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes
...savvy leaders , ,The new University of Wisconsin-...neering Sciences (SMILES) MBA degree is an innov...University of Wisconsin-Madisons Management and Hu...o provide business expertise to students with degr...g fields. , ,Students enroll in the SMILES MBA pr...
...the U.S. Patent and Trade Office issued U.S. Paten...NA Polymerase and Uses Thereof to the Wisconsin A...agency of the University of Wisconsin-Madison. Co...intellectual property invented by its co-founder R...ison research group, which included ConjuGon scien...
...ging, but knowing how to conduct the proper interv...failure of getting the right person. If its a top ...o fully understand the qualifications of the candi...in place to evaluate the candidates job qualificat... hiring the right person. , ,Our current model is...
...ay announced a new portfolio of managed IP product...V Hosted IP Communication Service (HIPCS), which i...ounced today are new SBC PremierSERV IP-VPN option...2004. The customized IP-VPN network connections p...spectrum of IP applications, including VoIP. , ,IP...
Other Biology Technology:UWs Tech Students Gain MBA Business Expertise 2UWs Tech Students Gain MBA Business Expertise 3Improving the Hiring Process 2(Date:12/4/2008)...ofessor of biology in Arts & Sciences, has made a ...cleolar dominance, the silencing of an entire pare...or animal. , Since the machinery involved in n...hat can go haywire in diseases such as cancer, Pik...rtant implications for applied medical research. ...
(Date:12/4/2008)...orest University,s School of Biomedical Engineerin... received the Army Modeling and Simulation Award f...aff of the Army and Director of the Army presented... save eyesight and reduce morbidity and mortality ... selected from 57 applicants from around the natio...
(Date:12/4/2008)...hers are taking a closer look at the phosphoinosit...nue to demonstrate that inhibiting this biological...ngineering & Biotechnology News ( GEN ). The path...erentiation, and survival. In addition, it is part...le in cancer, according to the December issue of ...
(Date:12/4/2008)...r bonefish from Miami down to the Marquesas Island... is down slightly from the average of previous cen...hose who are counting, researchers speculate. The ...and Atmospheric Science held the sixth annual Flor...conservation group Bonefish & Tarpon Unlimited (BT...
Breaking Biology News(10 mins):Researchers solve piece of large-scale gene silencing mystery 2Researchers solve piece of large-scale gene silencing mystery 3Researchers solve piece of large-scale gene silencing mystery 4New dummy design and development wins US Department of Defense award 2Bonefish census reveals population holding steady 2Controversy About Lack of Placebo Group Decline in Alzheimers Clinical Trials 2715 1Controversy About Lack of Placebo Group Decline in Alzheimers Clinical Trials 2715 2Controversy About Lack of Placebo Group Decline in Alzheimers Clinical Trials 2715 3Controversy About Lack of Placebo Group Decline in Alzheimers Clinical Trials 2715 4Controversy About Lack of Placebo Group Decline in Alzheimers Clinical Trials 2715 5New Research on Pre Eclampsia in Mice May Have Important Implications for Humans 2713 1New Research on Pre Eclampsia in Mice May Have Important Implications for Humans 2713 2Polyphenon Pharma Receives Orphan Drug Designation for Its Botanical Drug Polyphenon E for the Treatment of CLL 2711 1Polyphenon Pharma Receives Orphan Drug Designation for Its Botanical Drug Polyphenon E for the Treatment of CLL 2711 2Alleviating the fear of falling 24438 1Alleviating the fear of falling 24438 2... the brain thought to act in reward circuitry may ...h sexual orientation modulates how we perceive ind...tas Kranz and Alumit Ishai of the University of Zu...ans, face recognition is arguably the most develop... brain,s cortical network for face perception incl...
...of the National Academy of Sciences on 11 April de...vered the mechanism allowing Vaccinia virus to she...chanism is unique in virology and paves the way fo...ses, such as influenza, are surrounded by a single...his membrane must be removed. Previously, all enve...
...olated jungles ?in the mist-shrouded Foja Mountain...st World" of new species, giant flowers, and rare ...er 2005 trip by a team of U.S., Indonesian, and Au...nal (CI) found dozens of new species including fro...eater, the first new bird from the island of New G...
...all intestine may hold the key to preventing infec...tions such as obstructive jaundice or irritable bo...al Center have discovered. , "What we,ve identifi... the number of bacteria low in the small intestine... organs," said Dr. Steven Kliewer, professor of mo...
Other Biology News:Face perception is modulated by sexual orientation 2Face perception is modulated by sexual orientation 3Face perception is modulated by sexual orientation 4Scientists discover dozens of new species in 'Lost World' of western New Guinea 2Gut protein found to protect against infection and intestinal breakdown 2... of robotic workstations is designed for laborator... automation platform for routine sample preparatio...res, improving throughput, process consistency and...tware allows you to control the robotic and liquid...
Mouse monoclonal antibody to CDC2L5 - cell division cycle 2-like 5 (cholinesterase-related cell division controller)
FluoroGuard Antifade Reagent from Bio-Rad
Mouse polyclonal antibody to GRID2 - glutamate receptor, ionotropic, delta 2
Biology Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |